Nutrition
Volume 26, Issue 11 , Pages 1122-1129 , November 2010

Perioperative tight glucose control with hyperinsulinemic-normoglycemic clamp technique in cardiac surgery

  • Hiroaki Sato, M.D.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • George Carvalho, M.D., M.Sc.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Tamaki Sato, M.D.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • David Bracco, M.D., Ph.D.

      Affiliations

    • Department of Anesthesia, Montreal General Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Takumi Codere-Maruyama

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Ralph Lattermann, M.D., Ph.D.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Roupen Hatzakorzian, M.D.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Takashi Matsukawa, M.D., Ph.D.

      Affiliations

    • Department of Anesthesiology, Yamanashi University, Yamanashi, Japan
    • ,
  • Thomas Schricker, M.D., Ph.D.

      Affiliations

    • Department of Anaesthesia, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +514-934-1934, ext. 34883; fax: +514-843-1698.

Received 6 July 2009 ,Accepted 13 October 2009.

References 

  1. Schricker T, Lattermann R, Schreiber M, Geisser W, Georgieff M, Radermacher P. The hyperglycemic response to surgery: pathophysiology, clinical implications and modification by the anaesthetic technique. Clin Intensive Care. 1998;9:118–128
  2. Schricker T, Lattermann R. Strategies to attenuate the catabolic response to surgery and improve perioperative outcomes. Can J Anaesth. 2007;54:414–419
  3. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004;99:319–324
  4. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg. 1999;89:1091–1095
  5. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518–1524
  6. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103:687–694
  7. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144
  8. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862–866
  9. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med. 1998;26:225–235
  10. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–982
  11. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–1478
  12. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367
  13. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–1021
  14. Rassias AJ. Intraoperative management of hyperglycemia in the cardiac surgical patient. Semin Thorac Cardiovasc Surg. 2006;18:330–338
  15. Butterworth J, Wagenknecht LE, Legault C, Zaccaro DJ, Kon ND, Hammon JW, et al. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005;130:1319
  16. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233–243
  17. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139
  18. Devos P, Preiser J, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the glucontrol study (European Society of Intensive Care Medicine 20th Annual Congress abstract 0735). Intensive Care Med. 2007;33(suppl 2):S189
  19. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–252
  20. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300:933–944
  21. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461
  22. Taylor BE, Schallom ME, Sona CS, Buchman TG, Boyle WA, Mazuski JE, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006;202:1–9
  23. Toft P, Jorgensen HS, Toennesen E, Christiansen C. Intensive insulin therapy to non-cardiac ICU patients: a prospective study. Eur J Anaesthesiol. 2006;23:705–709
  24. Oksanen T, Skrifvars MB, Varpula T, Kuitunen A, Pettila V, Nurmi J, et al. Strict versus moderate glucose control after resuscitation from ventricular fibrillation. Intensive Care Med. 2007;33:2093–2100
  25. McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, et al. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care. 2007;22:112–119
  26. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–3197
  27. Iapichino G, Albicini M, Umbrello M, Sacconi F, Fermo I, Pavlovich R, et al. Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients. Intensive Care Med. 2008;34:1843–1850
  28. Pachler C, Plank J, Weinhandl H, Chassin LJ, Wilinska ME, Kulnik R, et al. Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients. Intensive Care Med. 2008;34:1224–1230
  29. Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009;110:611–619
  30. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297
  31. Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38:1123–1129
  32. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096–1105
  33. Lecomte P, Foubert L, Nobels F, Coddens J, Nollet G, Casselman F, et al. Dynamic tight glycemic control during and after cardiac surgery is effective, feasible, and safe. Anesth Analg. 2008;107:51–58
  34. Saager L, Collins GL, Burnside B, Tymkew H, Zhang L, Jacobsohn E, et al. A randomized study in diabetic patients undergoing cardiac surgery comparing computer-guided glucose management with a standard sliding scale protocol. J Cardiothorac Vasc Anesth. 2008;22:377–382
  35. Hovorka R, Kremen J, Blaha J, Matias M, Anderlova K, Bosanska L, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007;92:2960–2964
  36. Carr JM, Sellke FW, Fey M, Doyle MJ, Krempin JA, de la Torre R, et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80:902–909
  37. Groban L, Butterworth J, Legault C, Rogers AT, Kon ND, Hammon JW. Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2002;16:405–412
  38. Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA, et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth. 2005;95:448–457
  39. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497–1502
  40. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol Endocrinol Metab. 1981;240:E630–E639
  41. Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes. 1993;42:405–410
  42. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism. 1988;37:15–21
  43. van Wezel HB, Zuurbier CJ, de Jonge E, van Dam EW, van Dijk J, Endert E, et al. Differential effects of a perioperative hyperinsulinemic normoglycemic clamp on the neurohumoral stress response during coronary artery surgery. J Clin Endocrinol Metab. 2006;91:4144–4153
  44. Kaukonen KM, Rantala M, Pettila V, Hynninen M. Severe hypoglycemia during intensive insulin therapy. Acta Anaesthesiol Scand. 2009;53:61–65
  45. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin–glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65
  46. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650–661
  47. Dickerson RN, Swiggart CE, Morgan LM, Maish GO, Croce MA, Minard G, et al. Safety and efficacy of a graduated intravenous insulin infusion protocol in critically ill trauma patients receiving specialized nutritional support. Nutrition. 2008;24:536–545
  48. Mellbin LG, Malmberg K, Waldenstrom A, Wedel H, Ryden L. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. Heart. 2009;95:721–727
  49. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687
  50. Carvalho G, Moore A, Albacker T, Lachapelle K, Schricker T. Cardioprotective effect of insulin and maintenance of normoglycemia. Can J Anaesth. 2006;53(Suppl):26481
  51. Zuurbier CJ, Hoek FJ, van Dijk J, Abeling NG, Meijers JC, Levels JH, et al. Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth. 2008;100:442–450
  52. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785–789
  53. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–1129
  54. Doenst T, Bugger H, Schwarzer M, Faerber G, Borger MA, Mohr FW. Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg. 2008;33:862–871
  55. Bonadonna RC, Groop LC, Simonson DC, DeFronzo RA. Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle. Am J Physiol Endocrinol Metab. 1994;266:E501–E509
  56. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol Endocrinol Metab. 1999;276:E1055–E1066
  57. Mittelman SD, Bergman RN. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am J Physiol Endocrinol Metab. 2000;279:E630–E637
  58. Luo M, Fernandez-Estivariz C, Jones DP, Accardi CR, Alteheld B, Bazargan N, et al. Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation. Nutrition. 2008;24:37–44
  59. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol. 1975;36:938–953
  60. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106:160–163
  61. Hovorka R. The future of continuous glucose monitoring: closed loop. Curr Diabetes Rev. 2008;4:269–279
  62. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009;53:66–71
  63. Juneja R, Roudebush C, Kumar N, Macy A, Golas A, Wall D, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9:232–240
  64. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28:2418–2423
  65. Clinicaltrials.gov. Available at: http://www.clinicaltrial.gov/ct2/show/NCT00524472. Accessed June 17, 2009.

 Dr. Sato is supported by a grant from the Research Institute of Yamanashi University, Japan. Drs. Carvalho and Lattermann are supported by grants from the Research Institute of the McGill University Health Center, Montreal, Canada. Dr. Schricker is receiving funds from the Canadian Institutes of Health Research, Ottawa, Canada.

PII: S0899-9007(09)00429-8

doi: 10.1016/j.nut.2009.10.005

Nutrition
Volume 26, Issue 11 , Pages 1122-1129 , November 2010

Article Tools

* Image Usage & Resolution